IDYA IDEAYA Biosciences, Inc

NASDAQ
$36.69

IDEAYA Biosciences, Inc (IDYA) is expected to report earnings on November 9, 2026, before the market open. The consensus earnings estimate is a loss of $1.28 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +1.1% since its last earnings release on August 4, 2026.

IDEAYA Biosciences Missed Consensus Estimates
Tuesday, August 4, 2026 · 6:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 6:00 AM ET
Earnings Whisper
-
vs ($1.28)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $38.54

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About IDEAYA Biosciences, Inc

IDEAYA is a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.

Sector

Healthcare

Industry

Biotechnology

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.